Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity
El Newahie A.M.S.; Ismail N.S.M.; Abou El Ella D.A.; Abouzid K.A.M.
Date issued:
2016
Publisher:
Wiley-VCH Verlag
Series Info:
Archiv der Pharmazie
349
Type:
Review
Keywords:
Anticancer
,
Kinase inhibitors
,
Quinoxalines
,
SAR
,
Synthetic strategies
,
antineoplastic agent
,
cyclin dependent kinase 1
,
cyclin dependent kinase 2
,
cyclin dependent kinase 4
,
cyclin dependent kinase 6
,
doxorubicin
,
Janus kinase 2 inhibitor
,
protein kinase inhibitor
,
protein tyrosine kinase inhibitor
,
quinoxaline derivative
,
vasculotropin inhibitor
,
antineoplastic agent
,
protein kinase inhibitor
,
protein tyrosine kinase
,
quinoxaline derivative
,
antineoplastic activity
,
biological activity
,
drug cytotoxicity
,
drug synthesis
,
drug targeting
,
human
,
nonhuman
,
priority journal
,
Review
,
structure activity relation
,
antagonists and inhibitors
,
chemical structure
,
chemistry
,
molecular model
,
synthesis
,
Antineoplastic Agents
,
Humans
,
Models, Molecular
,
Molecular Structure
,
Protein Kinase Inhibitors
,
Protein-Tyrosine Kinases
,
Quinoxalines
,
Structure-Activity Relationship
Abstract:
Quinoxaline derivatives, also called benzopyrazines, are an important class of heterocyclic compounds. Quinoxalines have drawn great attention due to their wide spectrum of biological activities. They are considered as an important basis for anticancer drugs due to their potential activity as protein kinase inhibitors. In this review, we focus on the chemistry of the quinoxaline derivatives, the strategies for their synthesis, their potential activities against various tyrosine kinases, and on the structure-activity relationship studies reported to date. � 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Description:
Scopus
MSA Google Scholar
Show full item record